IDEXX Laboratories (Germany) Top Insiders

IX1 Stock  EUR 527.20  1.80  0.34%   
IDEXX Laboratories employs about 11 K people. The company is managed by 17 executives with a total tenure of roughly 25667 years, averaging almost 1509.0 years of service per executive, having 647.06 employees per reported executive. Examination of IDEXX Laboratories' management performance can provide insight into the company performance.
Jonathan Mazelsky  CEO
CEO President
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in IDEXX Laboratories. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation.
For more detail on how to invest in IDEXX Stock please use our How to Invest in IDEXX Laboratories guide.

IDEXX Laboratories Management Team Effectiveness

The company has return on total asset (ROA) of 0.2559 % which means that it generated a profit of $0.2559 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.662 %, meaning that it generated $0.662 on every $100 dollars invested by stockholders. IDEXX Laboratories' management efficiency ratios could be used to measure how well IDEXX Laboratories manages its routine affairs as well as how well it operates its assets and liabilities. At this time, IDEXX Laboratories' Other Current Assets are most likely to decrease significantly in the upcoming years. The IDEXX Laboratories' current Non Currrent Assets Other is estimated to increase to about 359.6 M, while Total Current Assets are projected to decrease to roughly 1.1 B.

IDEXX Laboratories Quarterly Income Before Tax

344.77 Million

The current Common Stock Shares Outstanding is estimated to decrease to about 67.6 M. The current Net Income Applicable To Common Shares is estimated to decrease to about 448.5 MIDEXX Laboratories has a total of 79.85 Million outstanding shares. The majority of IDEXX Laboratories outstanding shares are owned by outside corporations. These institutional investors are usually referred to as non-private investors looking to purchase positions in IDEXX Laboratories to benefit from reduced commissions. Thereupon, third-party entities are subject to a different set of regulations than regular investors in IDEXX Laboratories. Please pay attention to any change in the institutional holdings of IDEXX Laboratories as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Some institutional investors establish a significant position in stocks such as IDEXX Laboratories in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of IDEXX Laboratories, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.

IDEXX Laboratories Workforce Comparison

IDEXX Laboratories is currently regarded as number one stock in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 58,391. IDEXX Laboratories retains roughly 11,000 in number of employees claiming about 19% of equities under Health Care industry.
The company has Profit Margin (PM) of 0.25 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.29 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.29.

IDEXX Laboratories Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. IDEXX Laboratories Price Series Summation is a cross summation of IDEXX Laboratories price series and its benchmark/peer.

IDEXX Laboratories Notable Stakeholders

An IDEXX Laboratories stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as IDEXX Laboratories often face trade-offs trying to please all of them. IDEXX Laboratories' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting IDEXX Laboratories' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Jonathan MazelskyCEO PresidentProfile
Andrew EmersonCFO VPProfile
Sharon JDGeneral VPProfile
Amit GuptaChief VPProfile
Nimrata PEExecutive CommercialProfile
Martin SmithExecutive RDProfile
Julie GodonSenior OfficerProfile
Michael LaneDiagnostic LaboratoriesProfile
Jeffery ChadbourneDirector ReportingProfile
George FennellExecutive CommercialProfile
Sharon UnderbergGen VPProfile
Ken GradyVP OfficerProfile
Bob AsmannSenior OperationsProfile
Michael JohnsonExecutive OfficerProfile
James PolewaczykEx OfficerProfile
John HartVP OperationsProfile
Brian McKeonEx CFOProfile
String symbol = request.getParameter("s");

About IDEXX Laboratories Management Performance

The success or failure of an entity such as IDEXX Laboratories often depends on how effective the management is. IDEXX Laboratories management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of IDEXX management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the IDEXX management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
IDEXX Laboratories, Inc., together with its subsidiaries, develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. IDEXX Laboratories, Inc. was founded in 1983 and is headquartered in Westbrook, Maine. IDEXX Laboratories operates under Diagnostics Research classification in Germany and is traded on Frankfurt Stock Exchange. It employs 8000 people.

IDEXX Laboratories Workforce Analysis

Traditionally, organizations such as IDEXX Laboratories use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare IDEXX Laboratories within its industry.

IDEXX Laboratories Manpower Efficiency

Return on IDEXX Laboratories Manpower

Revenue Per Employee354.3K
Revenue Per Executive229.3M
Net Income Per Employee80.7K
Net Income Per Executive52.2M
Working Capital Per Employee30.2K
Working Capital Per Executive19.5M

Complementary Tools for IDEXX Stock analysis

When running IDEXX Laboratories' price analysis, check to measure IDEXX Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IDEXX Laboratories is operating at the current time. Most of IDEXX Laboratories' value examination focuses on studying past and present price action to predict the probability of IDEXX Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IDEXX Laboratories' price. Additionally, you may evaluate how the addition of IDEXX Laboratories to your portfolios can decrease your overall portfolio volatility.
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
CEOs Directory
Screen CEOs from public companies around the world
Commodity Directory
Find actively traded commodities issued by global exchanges
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.